Status:
COMPLETED
The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Healthcare Workers
Covid19
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Vaccine hesitancy also concerns healthcare workers (HCWs). However, HCWs are at the frontline of the COVID-19 pandemic and identified as a priority target group for COVID-19 vaccines. Thus, the identi...
Detailed Description
Most countries face the issue of vaccine hesitancy, with sizeable fractions, or sometimes the majority, of the public opposing some vaccines. The problem is particularly acute in the case of COVID-19 ...
Eligibility Criteria
Inclusion
- Legal age
- Healthcare workers defined as individuals who currently work in a setting where individuals receive healthcare (i.e. individuals do not have to work directly with patients, but may have any role within a setting where individuals receive healthcare, such as administrative office, housekeeping, food service, etc.)
- Included in ESPERES cohort and with the initial questionnaire completed
- Agreeing to participate (digital consent)
Exclusion
- No internet access
- Vaccinated against COVID-19 (at least one dose)
Key Trial Info
Start Date :
May 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04881227
Start Date
May 25 2021
End Date
October 15 2021
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pitié-Salpêtrière - Charles Foix, AP-HP
Paris, Île-de-France Region, France, 75013